Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The Drugs To Watch report published annually by Clarivate includes 11 new medicines either in Phase II/III clinical development, pre-registration/registration or already launched in 2025
How deep into the brain do they get? Hayes asks
What sets this formula apart is its thoughtful balance of efficacy and comfort
L4 radiculopathy: Presents with ankle dorsiflexion weakness and an absent patellar reflex
US$ 26.79
US$ 23.73
US$ 20.35
US$ 21.43
US$ 20.78
US$ 20.62
US$ 24.89
US$ 26.53
US$ 28.99
US$ 27.41
